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Abstract
Purpose We hypothesized that, because of persistent
stunning, the extent of post-treatment functional abnormal-
ities detected using gated single-photon emission computed
tomography (SPECT) could be representative of the initial
risk area in acute myocardial infarction (AMI) treated by
reperfusion therapy.
Materials and methods In 48 AMI patients, we acquired
two 99mTc-sestamibi gated SPECT studies (at admission
with tracer injection before treatment and at discharge 5 to
10 days later). We assessed the myocardial salvage defined
by the admission minus predischarge summed rest score,
and we compared it with the value obtained by subtracting
the extent of perfusion defect from the extent of wall
motion or wall thickening abnormalities in predischarge
gated SPECT. Myocardial salvage was expressed as salvage
index (salvaged myocardium divided by initial risk area).
Results There was a good correlation between summed rest
score salvage index and wall motion (Spearman’s ρ=0.754,
p<0.0001) or wall thickening salvage index (Spearman’s
ρ=0.798, p<0.0001). The wall thickening salvage index
was able to classify correctly the patients that had a
summed rest score salvage index≥0.10 with 73% sensitiv-
ity, 88% specificity, and 83% accuracy. The wall motion
salvage index was highly sensitive (91%) but poorly specific
(13%, p<0.002 vs wall thickening salvage index) and less
accurate (69%, p<0.05 vs wall thickening salvage index).
Conclusions 99mTc-sestamibi gated SPECT allows assess-
ing myocardial salvage using only post-treatment data. The
salvage index derived using wall thickening as surrogate of
admission perfusion defect correlates well with the salvage
index measured by comparing pre- and post-treatment
perfusion defects.
Keywords Angioplasty .Myocardial infarction .Myocardial
stunning . Tomography . Emission computed . Single photon
Introduction
The success of reperfusion therapy in acute myocardial
infarction (AMI) is related to the amount of myocardium at
risk, the presence of residual blood flow or collateral cir-
culation, and the duration of coronary occlusion [1–4].
These factors are the major determinants of the extent of
myocardial salvage that can be obtained and, thus, of the
final infarct size [5]. In turn, infarct size is the main deter-
minant of a patient’s benefit in terms of functional recovery
and clinical outcome after reperfusion therapy [6, 7].
Single-photon emission computed tomography (SPECT)
with 99mTc-labeled myocardial perfusion agents is consid-
ered a most reliable method to identify salvaged myocar-
dium. Perfusion SPECT performed after the tracer has been
injected before reperfusion therapy visualizes the area at
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risk. A second SPECT study performed days to weeks after
an intervention permits to assess the final infarct size [8–
11]. The difference between the two uptake defects
represents the salvaged myocardium. Therefore, this ap-
proach allows the direct measurement of myocardial
salvage, differently from what happens using the indirect
markers of reperfusion success, such as rapid resolution of
ST-segment elevation [12] or myocardial blush [13].
Unfortunately, the need to avoid any unnecessary delay in
reperfusion treatment limits the feasibility of prereperfusion
99mTc-sestamibi SPECT. Therefore, in clinical practice, the
role of 99mTc-sestamibi SPECT for estimating the success
of reperfusion therapy is mainly based on the measurement
of final infarct size, and no data about the initial risk area
are usually provided [14, 15]. After prolonged acute
ischemic injury and even if reperfusion has been successful,
myocardial stunning may occur and usually lasts for days to
weeks [16]. Myocardial stunning is associated with a
perfusion–function mismatch [17]. Gated SPECT is an
accurate and well-validated method for simultaneously
assessing perfusion, and regional and global left ventricular
function [18]. As gated SPECT allows the assessment of
regional function and perfusion without realignment prob-
lems, we hypothesized that the size of the stunned
asynergic area in post-treatment gated SPECT could still
be representative of the extent of initial area at risk and that
the difference between this area and the post-treatment




Our patient population consisted of the patients enroled in
our institution in the context of the Brave-2 trial [19]. A
total of 50 patients were referred to our laboratory for the
Brave-2 trial. ST elevation AMI diagnosis was based on
chest pain episode lasting ≥20 min between 12 and 48 h
before presentation and ST-segment elevation ≥0.1 mV in
two or more adjacent limb leads or ≥0.2 mV in two or more
contiguous precordial leads or new pathological Q-waves
on surface electrocardiogram. Exclusion criteria included
persistent anginal chest pain, cardiogenic shock, electrical
instability, severe congestive heart failure and/or pulmonary
edema, or previous stroke (within the last 3 months); before
thrombolysis for index infarction, recent percutaneous
coronary intervention (within the last 30 days), active
bleeding or bleeding diatheses, recent trauma or major
surgery (during the last month), relevant hematologic
deviations or malignancies, known or suspected pregnancy,
inability to comply with study procedures, and unwilling-
ness or inability to provide written informed consent for
participation [19].
Study protocol
The 50 Brave-2 trial eligible patients at our institution
underwent the 99mTc-sestamibi injection (740 MBq) at
admission before randomization. For that reason, in the
invasive therapy group, the injection was performed before
reperfusion. Admission gated SPECT imaging at rest was
obtained after 1 h in patients randomized to conservative
strategy and after coronary angiography and reperfusion in
patients randomized to invasive therapy. A second resting
gated SPECT study after injection of the same tracer dosage
(predischarge gated SPECT) was performed 5 to 10 days
later (mean, 5.9±1 days) [19]. In two patients, however, the
gated acquisition was unreliable because of technical
default in one case and because of atrial fibrillation in the
other subject. Therefore, the final study cohort of the
present study included 48 patients (mean age, 65.4±
11 years, range 41−84). All patients gave informed consent
to participate in the study, which was approved by the
Ethics Committees of our institution.
Gated SPECT
In 23 patients, scintigraphic images were acquired using a
dual-head gamma camera (Skylight, Philips, Milpitas, CA,
USA) and in 25 patients using a variable triple-head gamma
camera (Irix, Marconi-Philips, Cleveland, OH, USA).
Both gamma cameras were equipped with high-resolution
collimators and employed a 15% window centered on the
140-keV photopeak of 99mTc. SPECT was acquired in step-
and-shoot mode using a 180° elliptical orbit, matrix size
64×64, 8 frame/cardiac cycle for both gamma camera
systems, with 32 projections and 60 s per projection, or
with 34 projections and 30 s per projection, respectively, for
the Skylight and for the Irix system. SPECT images were
reconstructed using filtered back-projection without atten-
uation or scatter correction and realigned along the heart
axis. For each patient, the same gamma camera was used
for the two SPECT acquisitions.
Data analysis
For perfusion and function analysis, the left ventricular polar
map was divided into 20 segments. Regional myocardial
perfusion, wall motion, and thickening were assessed
visually by one blinded experienced observer, unaware of
patient’s data and image sequence, and they were scored
using a five-point scale (0 = normal, 1 = mildly reduced, 2 =
moderately reduced, 3 = severely reduced, 4 = absent
uptake) [20], a six-point scale (0 = normal, 1 = mild
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hypokinesia, 2 = moderate hypokinesia, 3 = severe hypo-
kinesia, 4 = akinesia, 5 = dyskinesia), and a four-point scale
(0 = normal, 1 = mildly impaired, 2 = moderately impaired,
and 3 = severely impaired thickening), respectively [21].
Because these widely used scoring schemes are hetero-
geneous, to allow the comparison between perfusion and
wall motion or wall thickening, the scores were translated
in extent of abnormality on the polar maps and expressed as
percentage of the left ventricular wall. Therefore, the extent
of any abnormality (perfusion, wall motion, or wall
thickening) was
number of abnormal segments
20
 100
As the perfusion and wall motion scoring schemes
included a higher number of degrees, we did not consider
abnormal the segments with borderline perfusion or wall
motion anomalies (score=1). We used as reference to
establish the salvaged myocardium the difference between
the admission and the predischarge summed rest score. The
salvaged myocardium divided by the initial risk area
defined the salvage index; according to prior data, a salvage
index<0.10 was considered to indicate negligible treatment
benefit [22]. The reference salvage index obtained using the
summed rest score was compared with the salvage index
calculated as (1) the extent of wall motion abnormalities in
predischarge gated SPECT minus perfusion defect extent in
predischarge gated SPECT divided by the extent of wall
motion anomalies in predischarge gated SPECT (wall
motion salvage index) and (2) the extent of wall thickening
in predischarge gated SPECT minus perfusion defect extent
in predischarge gated SPECT divided by extent of wall
thickening anomalies in predischarge gated SPECT (wall
thickening salvage index).
Statistical analysis
Continuous variables are expressed as mean ± standard
deviation. Discrete variables are expressed as median and
interquartile range. The comparisons between groups were
performed with the Wilcoxon test for dependent samples.
The correlation between variables was evaluated using the
Spearman’s ρ. The comparison of proportion was made




The patient population included 34 men and 14 women. Of
them, 28 patients were assigned to the invasive group and
20 patients to the conservative group. No patient had
history of prior percutaneous coronary intervention and/or
coronary artery bypass grafting. As regards the infarct
location, 18 patients had anterior, 23 inferior, and 7 lateral
infarction. Table 1 summarizes the characteristics of the
patient population.
Myocardial perfusion
At admission, the median (25th, 75th percentiles) of
summed rest score was 21.5 (14.5, 32), and the extent of
perfusion abnormalities was 35% (25%, 50%). The median
predischarge summed rest score was 17 (6.25, 22.5; p<
0.0001 vs admission) and the extent of perfusion abnormal-
ities was 30% (10%, 40%; p<0.0001 vs admission). The
salvage index derived from the admission vs predischarge
summed rest score was 0.33 (0, 0.57). The salvage index
derived from percent extent of perfusion defects was 0.25
(0, 0.56). This value showed a close correlation with the
summed rest score salvage index, with Spearman’s ρ=0.943
(p<0.0001).
Salvage index according to functional vs perfusion
abnormalities in predischarge gated SPECT
The wall motion salvage index was 0.44 (0.27, 0.60). The
correlation between the summed rest score salvage index and
the wall motion salvage index was good, with Spearman’s
ρ=0.754, p<0.0001. The wall thickening salvage index was
Table 1 Clinical characteristics of the patient population
Characteristic Value
Age (mean ± SD) 65.4±11
Men 34 (70.8%)
Women (%) 14 (29.2%)
Risk factors
Family history of coronary artery disease 5 (10.4%)
Systemic arterial hypertension 20 (41.7%)
Hypercholesterolemia (total cholesterol>200 mg/dl 12 (25%)
Diabetes mellitus 6 (12.5%)
History of smoking 26 (54.2%)
Previous myocardial infarction 3 (6%)
Prior coronary artery by-pass grafting 0






Conservative strategy 20 (41.7%)
Invasive strategy 28 (58.3%)
Symptoms to admission gated SPECT delay
(hours, mean ± SD)
27±9
Peak CK (U/L, mean ± SD) 1,012±855
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0.25 (0, 0.60). The correlation between summed rest score
salvage index and wall thickening salvage index was good,
with Spearman’s ρ=0.798, p<0.0001.
The sensitivity, specificity, and accuracy of a wall
motion salvage index ≥0.10 for recognizing a summed rest
score salvage index ≥0.10 were 91, 13, and 69%,
respectively. Conversely, a wall thickening salvage index
≥0.10 showed 73% sensitivity, 88% specificity (p<0.002 vs
wall motion salvage index), and 83% accuracy (p<0.05 vs
wall motion salvage index) for recognizing a summed rest
score salvage index ≥0.10 (Fig. 1). Moreover, the wall
thickening salvage index was able to classify correctly as
belonging to the same quartile as the summed rest score
salvage index 10 of 13 patients of the lower quartile, 10 of
14 patients of the upper quartile, and 13 of 21 patients of
the two intermediate quartiles.
Discussion
In the present investigation, we tested the hypothesis that
the stunned asynergic area size in predischarge gated
SPECT could still be representative of the extent of initial
ischemia (myocardium at risk) and that the difference
between this area and the corresponding perfusion defect
size could be an approximate estimate of salvaged myocar-
dium. This hypothesis was based on the concept that
myocardial stunning persists days to weeks after reperfusion
therapy, and it is associated with a flow–functional
mismatch [17]. For this particular aim, we took advantage
from the use of gated SPECT that is very well suited to
allow the direct comparison of regional functional and
perfusion abnormalities, without realignment problems [18].
We registered a good correlation between the salvage
index derived from admission vs predischarge summed rest
score, which we used as reference standard, and the salvage
indexes derived from the difference in predischarge gated
SPECT between the extent of wall motion or wall
thickening abnormalities and the extent of perfusion
defects. Our results showed that the correlation between
summed rest score salvage index and the salvage index
derived using the wall thickening abnormalities as surrogate
for the admission perfusion defect was higher than the
corresponding value derived using the wall motion abnor-
malities. The latter approach was indeed highly sensitive
but unacceptably poorly specific for recognizing the
presence of summed rest score salvage index ≥0.10 and,
hence, to exclude a negligible treatment benefit [22]. On the
other hand, the wall thickening salvage index was signif-
icantly more accurate and, particularly, much more specific
in identifying the patients with a summed rest score salvage
index ≥0.10. Moreover, the wall thickening salvage index
was able to correctly classify the majority of the patients (33
of 48=69%) in the same quartile of the summed rest score
salvage index. The superiority of wall thickening over wall
motion for the detection of myocardial stunning could be
explained by the differences between wall motion and wall
thickening abnormalities already described by others using
gated SPECT visual assessment in the setting of myocardial
infarction [23]. However, we cannot exclude some influ-
ence of the relatively prolonged delay of the second gated
SPECT on the difference in accuracy between wall motion
and thickening for the estimate of the salvage index.
The importance of achieving an estimate of area at risk
in the evaluation of AMI cannot be overemphasized
because only the direct measurement of myocardial salvage
allows assessment of the individual response to intervention
in AMI [24]. Moreover, myocardial salvage has a major
prognostic meaning [25]. The measurement of area at risk
by 99mTc-sestamibi SPECT injected during coronary occlu-
sion has been extensively validated, and the salvaged
myocardium can be accurately obtained by the comparison
with a subsequent pre discharge rest perfusion scan that
identifies the final infarct size [8–11], but the early images
can be challenging to obtain. A retrospective evaluation of
the area at risk on an image acquired after the acute
presentation would be highly desirable. Various experimen-
tal and human studies have aimed to this goal. The fatty
acid tracer 123I-β-methyl-p-iodophenyl-pentadecanoic acid
(BMIPP) has been shown to demonstrate the persistence of
decrease in β-oxidation after inducible ischemia, and thus,
the BMIPP uptake defect early after myocardial infarction
could approximate the area at risk in comparison with
the 201Tl perfusion defect showing the infarct size [26]. The
unavailability of BMIPP in most countries has limited the
feasibility of this combined tracer method. In the experi-
mental animal, 18F-fluorodeoxyglucose also shows persis-
tent glucose metabolism derangement after ischemia [27].
Using an approach quite similar to ours, Main et al.
Fig. 1 Bar chart showing sensitivity, specificity, and accuracy of wall
motion salvage index (white bars), and wall thickening salvage index
(hatched bars) for recognizing a summed rest score salvage index≥0.10
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identified the stunned, reperfused myocardium after AMI as
perfusion–contraction mismatch in real-time myocardial
contrast echocardiography performed in a mean of 2.2 days
after hospital admission [28]. In this instance, the total
extent of abnormal contraction would be the expression of
the risk area and the contrast defect of the final infarct size.
The several advantages of echocardiography over the other
imaging modalities would support the use of this method;
however, poor acoustic window and the additional technical
problems specific to myocardial contrast echocardiography
could limit its feasibility and reliability in a minority of
patients. Most recently, the comparison of T2 signal
increase and late-gadolinium-enhancement in magnetic
resonance imaging has been proposed, according to the
hypothesis that T2-weighted sequences depict myocardial
edema (and then the area at risk), while hyperenhancement
is confined to necrotic tissue (and then corresponds to the
final infarct size) [29]. The high resolution of magnetic
resonance imaging makes this last approach very attractive,
but so far no demonstration of its practicability and
reliability in humans is available.
Our results must be evaluated taking into account the
limitations of our study. A crucial issue to consider for the
retrospective evaluation of the risk area is the time course
of the changes of the parameter used to define the risk area
itself. In our study, the pre discharge gated SPECT acquired
five or more days after hospital admission could underes-
timate the area at risk because part of the stunning-
related functional abnormality could have already disap-
peared. As above stated, this prolonged delay could have
had as well some influence of the different accuracy of wall
motion vs wall thickening salvage index. On the other
hand, it must be noted that, in our series, the wall motion
(but not the wall thickening) abnormalities still overesti-
mate the area at risk. Certainly, it would be reasonable and
highly recommended to anticipate the post-intervention
gated SPECT acquisition to further improve the reliability
of our combined approach. The patient population was
quite small and heterogeneous, including both patients
submitted to mechanical reperfusion and patients treated
conservatively. Moreover, the number of patients with prior
infarction was very small, and none had history of previous
revascularization procedures. Therefore, further studies on
cohorts that better represent the usual patient population
submitted to percutaneous coronary intervention for AMI
are warranted. In addition, our patients were admitted for
AMI after a more prolonged delay than usual, and this
could have affected the absolute rate of treatment success.
However, each patient served as his/her own control, as the
salvage index was assessed with an established method by
means of the summed rest score. The criteria used to
compare perfusion and functional data by translating the
related scores in extent of abnormalities on the polar maps
were somewhat arbitrary. Using the automatic definition of
abnormalities in percent of left ventricle that is offered by
various processing algorithms for gated SPECT could im-
prove the reliability and reproducibility of our method.
Further studies on larger patient population submitted to the
same treatment within a more reasonable time frame will be
needed to definitively establish the value of the estimate of
salvaged myocardium by the comparison of functional vs
perfusion abnormalities in a single post-treatment gated
SPECT.
Conclusions
This study suggests that by comparing the extent of wall
thickening and perfusion abnormalities in a single post-
treatment gated SPECT, it is possible to have an approx-
imate but clinically effective estimate of the salvage index
in AMI patients. In spite of its limitations, the simplicity
and feasibility of this assessment would support its use to
define the success of reperfusion treatment in the individual
patient and increases the diagnostic value of perfusion
imaging using gated SPECT over its already established
role in defining the infarct size. Further studies on larger
and less selected patient populations using a more con-
trolled timetable for the post-intervention gated SPECT are
needed to confirm our preliminary results.
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